U.S. Markets open in 7 hrs, 28 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 19.84 09:49 AM EST | |
|---|---|---|
| Day High | 20.75 03:23 PM EST |
|
| Range | 0.91 |
| Volume | 807,268 | |
|---|---|---|
| 30-Day Avg Vol | 574,000 |
|
| Difference | 40.64% |
| Market Cap | 1.19 B | |
|---|---|---|
| Mkt Cap Chg | 37.66 M |
| Shares Out | 57.94 M | |
|---|---|---|
| % Shrs Traded | 1.39% | |
| 1yr EPS Est | 1.64 |
| 52-Wk Low | 13.81 | |
|---|---|---|
| 52-Wk High | 22.42 |
|
| Range | 8.61 |
| Prev Close | 19.93 2/8/10 | |
|---|---|---|
| Today's Open | 20.14 | |
| Change | 1.05% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.79 M |
| Revenue (LFY) | 562.14 M | |
|---|---|---|
| Earnings (LFY) | 79.60 M | |
| Earnings (MRQ) | 22.67 M | |
| Next Earn Est | 0.351 | |
| Next Earnings | 04/19/2010 |
|
| EPS (TTM) | 1.36 | |
| 1yr EPS Growth | 17.14% |
| P/E Ratio (TTM) | 8.99 | |
|---|---|---|
| P/E Ratio (Fwd) | 12.00 | |
| PEG Ratio | 0.64 | |
| Return on Equity | 73.19 | |
| Beta | 0.61 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Fighting infection is a modern art form at Cubist Pharmaceuticals. The company is developing antimicrobial agents that aim to treat drug-resistant infections typically found in hospitals and other health ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.351 4/19/10 | — — |
—
—
|
| Last Quarter | 0.406 12/31/09 | 0.45 12/31/09 |
0.044
Beat
|
| 2 Quarters Ago | 0.328 9/30/09 | 0.42 9/30/09 |
0.092
Beat
|
| Quarterly - 12/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 166.72 M | 562.14 M |
| Gross Profit | 133.16 M | 445.26 M |
| Operating Income | 40.57 M | 137.76 M |
| Net Income | 22.67 M | 79.60 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts